The Food and Drug Administration (FDA) will issue sanctions to pharmaceutical companies who will not comply with the guidelines in following the Mexico City Principles (MCP) or voluntary code of ethics. Read More at http://balita.ph/

The clamor for transparency and accountability in healthcare practices and the push for adhering to codes of ethics are becoming stronger. Read More at https://business.inquirer.net/

This statement outlines priorities and recommendations that members of the United States Council for International Business (USCIB) would like to see advanced in 2014. Read the Statement at https://www.uscib.org/